JP2022525706A5 - - Google Patents

Info

Publication number
JP2022525706A5
JP2022525706A5 JP2022504738A JP2022504738A JP2022525706A5 JP 2022525706 A5 JP2022525706 A5 JP 2022525706A5 JP 2022504738 A JP2022504738 A JP 2022504738A JP 2022504738 A JP2022504738 A JP 2022504738A JP 2022525706 A5 JP2022525706 A5 JP 2022525706A5
Authority
JP
Japan
Prior art keywords
compound
pain
pharmaceutical composition
composition according
isomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022504738A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022525706A (ja
Filing date
Publication date
Priority claimed from GB1903900.7A external-priority patent/GB2582361A/en
Application filed filed Critical
Publication of JP2022525706A publication Critical patent/JP2022525706A/ja
Publication of JP2022525706A5 publication Critical patent/JP2022525706A5/ja
Pending legal-status Critical Current

Links

JP2022504738A 2019-03-21 2020-03-19 アデノシン受容体アゴニスト Pending JP2022525706A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1903900.7A GB2582361A (en) 2019-03-21 2019-03-21 Adenosine receptor agonists
GB1903900.7 2019-03-21
PCT/GB2020/050734 WO2020188288A1 (en) 2019-03-21 2020-03-19 Adenosine receptor agonists

Publications (2)

Publication Number Publication Date
JP2022525706A JP2022525706A (ja) 2022-05-18
JP2022525706A5 true JP2022525706A5 (cg-RX-API-DMAC7.html) 2023-03-27

Family

ID=66381433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504738A Pending JP2022525706A (ja) 2019-03-21 2020-03-19 アデノシン受容体アゴニスト

Country Status (5)

Country Link
US (1) US20220152077A1 (cg-RX-API-DMAC7.html)
EP (1) EP3941482A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022525706A (cg-RX-API-DMAC7.html)
GB (1) GB2582361A (cg-RX-API-DMAC7.html)
WO (1) WO2020188288A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113082020A (zh) * 2021-04-08 2021-07-09 徐州医科大学 一种腺苷受体激动剂的增强剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62692D0 (cg-RX-API-DMAC7.html) * 1992-05-14 1992-05-14 Novo Nordisk As
GB9930075D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930085D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930079D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
WO2005117910A2 (en) * 2004-05-26 2005-12-15 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
WO2011011919A1 (zh) * 2009-07-31 2011-02-03 新道生技股份有限公司 一种降血糖的组合物
JP2013523738A (ja) * 2010-03-26 2013-06-17 イノテック ファーマシューティカルズ コーポレイション アデノシン化合物およびそれらの使用
WO2017137528A1 (en) * 2016-02-12 2017-08-17 Charité - Universitätsmedizin Berlin Adenosine a1 receptor agonist for use in treatment of status epilepticus

Similar Documents

Publication Publication Date Title
JP6089045B2 (ja) 痛みの緩和または治療に使用するためのフェニルカルバメート化合物
JP2021105032A5 (cg-RX-API-DMAC7.html)
JP2013139446A5 (cg-RX-API-DMAC7.html)
JP2023508469A5 (cg-RX-API-DMAC7.html)
RU2003128535A (ru) Гетерополициклическое соединение (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, ассоциированного с активацией метаботропных глютаматных рецепторов (варианты)
JP2008520589A5 (cg-RX-API-DMAC7.html)
RU2009124541A (ru) Тозилатная соль терапевтического соединения и ее фармацевтические композиции
CN1235579C (zh) 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
JP2022515293A5 (cg-RX-API-DMAC7.html)
TWI389873B (zh) 阿戈美拉汀（ａｇｏｍｅｌａｔｉｎｅ）之新晶形iii，其製備方法及包含其之醫藥組合物
JP2024504252A5 (cg-RX-API-DMAC7.html)
JP2022539152A5 (cg-RX-API-DMAC7.html)
JP2011525185A5 (cg-RX-API-DMAC7.html)
JP2019529460A5 (cg-RX-API-DMAC7.html)
JP2019516756A5 (cg-RX-API-DMAC7.html)
FI3956310T3 (fi) Modifioituja aminohappojohdannaisia neurologisten sairauksien ja valittujen psykiatristen häiriöiden hoitamiseksi
JP2021534227A5 (cg-RX-API-DMAC7.html)
JP2022525706A5 (cg-RX-API-DMAC7.html)
JP2016537432A5 (cg-RX-API-DMAC7.html)
JP2014518552A5 (cg-RX-API-DMAC7.html)
JP2022512373A5 (cg-RX-API-DMAC7.html)
JP2019535715A5 (cg-RX-API-DMAC7.html)
JP2006511604A5 (cg-RX-API-DMAC7.html)
JP5341037B2 (ja) 双極性障害を処置するための医薬を得るためのアゴメラチンの使用
RU2019102757A (ru) Производные этинила